THE ALLOSOURCE ADVANTAGE
DOING MORE WITH LIFE
Our partners at Allosource are focused on transitioning scale-limited cellular therapies to an off the shelf, stable supply of cellular-based therapies that can be manufactured using allogeneic cell lines. Through our partnership, NKore will have the ability to mass produce therapeutics at scale for patients in need globally.
INTERNATIONAL SERVICES
AlloSource has evolved from a local tissue bank serving orthopedic surgeons in three states to an organization serving communities throughout the world. We are proud to help recipients inside and outside the United States Do More With Life.
Our current international communities include countries in:
The Asian Pacific Rim
The European Union
North America
Latin America
South America
In addition to our regulatory compliance listed in the Resource Center, AlloSource maintains compliance to the following Quality System requirements per:
Health Canada
Safety of Human Cells, Tissues and Organs for Transplant
European Parliament and Council of the European Union
Directive 2006/17/EC, Technical Requirements for the Donation, Procurement, and Testing of Human Tissues and Cells
Directive 2006/86/EC, Traceability Requirements, Notification of Serious Adverse Reactions and Events, and Certain Technical Requirements for the Coding, Processing, Preservation, Storage and Distribution of Human Tissues and Cells
Directive 2004/23/EC, Standards of Quality and Safety for Donation, Procurement, Testing, Processing, Preservation, Storage and Distribution of Human Tissues and Cells
